Skip to main content

Table 2 Baseline clinical characteristics and procedural details in the overall population

From: Efficacy of high-dose rosuvastatin preloading in patients undergoing percutaneous coronary intervention: a meta-analysis of fourteen randomized controlled trials

Variables

High-dose of RSV n/population (%)

Control n/population (%)

Number of patients

1671/3273 (51.1 %)

1602/3273 (48.9 %)

Male

1150/1671 (68.8 %)

1075/1602 (67.1 %)

Hypertension

1088/1671 (65.1 %)

988/1602 (61.7 %)

Diabetes Mellitus

473/1671 (28.3 %)

449/1602 (28.0 %)

Smoker

592/1606 (36.9 %)

573/1542 (37.2 %)

Previous MI

223/1067 (20.9 %)

224/1069 (21.0 %)

Previous PCI

160/1019 (15.7 %)

143/1017 (14.1 %)

Stable angina

732/1671 (43.8 %)

657/1602 (41.0 %)

NSTEMI

759/1671 (45.4 %)

759/1602 (47.3 %)

STEMI

181/1671 (10.8 %)

188/1602 (11.7 %)

Multi-vessel disease

198/644 (30.7 %)

157/633 (24.8 %)

B2/C lesions

654/918 (71.2 %)

590/855 (69.0 %)

Thrombus

122/757 (16.1 %)

135/763 (17.7 %)

LM

16/700 (2.3 %)

25/709 (3.5 %)

LAD

666/1253 (53.2 %)

619/1174 (52.7 %)

LCX

360/1315 (27.3 %)

354/1244 (28.4 %)

RCA

393/1253 (31.4 %)

368/1174 (31.3 %)

Multiple vessel PCI

216/644 (33.5 %)

203/768 (26.4 %)

Aspirin

1624/1671 (97.2 %)

1548/1602 (96.6 %)

Clopidogrel

1599/1605 (99.6 %)

1530/1536 (99.6 %)

β-blockers

952/1393 (68.3 %)

979/1402 (69.8 %)

ACEI/ARB

910/1393 (65.3 %)

953/1402 (67.9 %)

Glycoprotein IIb/IIIa inhibitors

76/1025 (7.4 %)

103/959 (10.7 %)

Numbers of DES

560/696 (80.5 %)

556/691 (80.5 %)

  1. Previous MI previous myocardial infarction, Previous PCI previous percutaneous coronary intervention, NSTE-ACS non-ST segment elevation acute coronary syndrome, STEMI ST segment elevation myocardial infarction, LM, left main, LAD left anterior descending, LCX left circumflex, RCA right coronary artery, DES drug-eluting stent